
    
      Design

        -  This trial is a randomized, double blind, placebo controlled trial with 80 patients.

        -  The trial will be implemented at Kyung Hee University Hospital at Gangdong in Seoul,
           Korea.

        -  Participants will take Korean red ginseng or placebo for 8 weeks and will be followed up
           during 4 weeks.

        -  During the administration period, 6 capsules 2 times a day (1h after breakfast and
           dinner) of Korean red ginseng or its placebo will be provided.
    
  